10+ can't-miss Houston business and innovation events for July

Where to be

From enlightening talks to networking opportunities, here's where you need to be in July. Getty Images

If you were hoping that business events would slow down for the summer, keep hoping. While you're probably getting plenty of OOO emails during your daily communications, there's no shortage of face-to-face opportunities within Houston business and innovation.

If you know of innovation-focused events for this month or next, email me at natalie@innovationmap.com with the details andsubscribe to our daily newsletterthat sends fresh stories straight to your inboxes every morning.

July 3 — Is Venture Capital Right for My Business?

Venture Capital is a path that every startup has to evaluate. In this panel-led event the intent is to form a foundation for answering the question: "Is VC right for me?"

Details: The event is from noon to 1:30 pm on Wednesday, July 3 at Station Houston (1301 Fannin Street, #2440). Learn more.

July 10 — Smart Cities: How Smart is Houston?

The Center for Houston's Future presents this event with support from graduates of its Leadership Forum program and in partnership with Station Houston, City of Houston's Innovation Office, and Houston Exponential.

The City of Houston is using data and emerging technology to improve the quality of life for citizens, share information with the public, drive economic growth and build a more inclusive society. Two key Smart City initiatives will be discussed at the event, one focused on transportation and one focused on resiliency and sustainability.

Details: The event is from 7:30 to 9:30 am on Wednesday, July 10, at Station Houston(1301 Fannin Street, #2440). Learn more.

July 10 — Social Advertising 101: Training by The Black Sheep Agency

Learn the basics of Facebook and Instagram advertising as Black Sheep professionals walk through the best type of #ad for your campaign! The team will also talk you through formulating a budget, targeting your audience, optimizing your efforts, and other creative options to execute your social advertising needs.

Details: The event is from 5:30 to 7:30 pm on Wednesday, July 10, at Impact Hub Houston #PopHUB @HX (410 Pierce Street). Learn more.

July 11 — Startup Pains: What I Wish I Knew

This monthly series hosted by the University of Houston lets you learn from someone else's mistakes and successes. This month's speaker is Carlos Genty, CEO & CTO of Critical X Solutions.

Details: The event is from 4 to 5 pm on Thursday, July 11, at the UH Technology Bridge (Innovation Center, building 4, floor 2, 5000 Gulf Fwy). Learn more.

July 13 — Enventure Basecamp - Business Building Workshop

Basecamp is an inclusive environment for those who are interested in adapting their life science experiences to real business applications. All are welcome, and the event is free.

Details: The event is from 9 am to noon on Saturday, July 13, at the TMC Innovation Institute (2450 Holcombe Blvd). Learn more.

July 15 — Enventure Innovation Stories: Dan Harrington, PhD (Polyvascular)

Enventure welcomes Daniel Harrington, PhD for its Innovation Stories speaker series. Dr. Harrington is a co-founder and the chief scientific officer of Polyvascular, and an assistant professor at UTHealth.

Details: The event is from 6 to 8:30 pm on Monday, July 15, at the CUBIO Innovation Center(7707 Fannin St.). Learn more.

July 16 — Is My Idea Lucrative? A Small Business Success Series Workshop

Figure out if whether your business idea is crazy — or perhaps just crazy enough to work. Featured presenters include Ned Mueller, entrepreneur in residence at HCC Center for Entrepreneurship - Southeast, and Austin Tenette is a certified business coach with the Focal Point Coaching organization.

Details: The event is from 8:30 am to 4:30 pm on Tuesday, July 16, at the HCC Alief Hayes (2811 Hayes Road). Learn more.

July 16 — GCxN Clean Tech Start-up Pitch Competition

The Shell GameChanger AcceleratorTM Powered by NREL, GCxN, is a collaboration between Shell and the National Renewable Energy Lab to identify and advance the next generation of transformative energy technologies. GCxN addresses market gaps by providing clean tech startups with technical and business development support to move their technologies from early stage prototypes to commercially viable energy solutions.

Details: The event is from 3 to 8 pm on Tuesday, July 16, at Station Houston (1301 Fannin St., suite 2440). Learn more.

July 16 — Workshop: Mastering the Brain Dump to Reduce Business Frustrations

Christina Wright, founder of WrightNow Results, will guide you through her method to help you get clear on — and develop a plan for — your biggest challenges surrounding business and managing "it all."

Details: The event is from 5:30 to 7:30 pm on Tuesday, July 18, at Impact Hub Houston #PopHUB @HX (410 Pierce Street). Learn more.

July 17 — Fuckup Nights Houston

Failure is a part of any success story, but we don't talk about it enough. We've all been to plenty of events where people tell you how they hacked, hustled, and created their success, but very few where someone gets up and says "I totally messed up, and this is what you can learn from it."

Details: The event is from 6 to 8 pm on Wednesday, July 17, at TBA. Learn more.

July 18 — Chancellor’s Technology Bridging Fund 2019 Launch Event

In an effort to support the University of Houston's mission of building a thriving culture around innovation and entrepreneurship amongst its faculty, staff and students, Chancellor Renu Khator has allocated $2 million into launching the Chancellor's Technology Bridging Fund (CTBF). This five-year proof-of-concept program is aimed to help our faculty inventors move their technologies closer to commercialization. Goals for the CTBF include prototyping, creating industry partnerships, and preparing for further funding.


Details: The event is from 5 to 7 pm on Thursday, July 18, at the UH Innovation Center(UH Technology Bridge, Building 4, Floor 2, 5000 Gulf Fwy). Learn more.

July 18 — TMCx alpha Opening Event

TMC alpha provides a pathway for any innovator affiliated with a TMC member institution to find support for the development and commercialization of their idea or product. The program will run every third Thursday (apart from where this conflicts with another function/holiday/etc.) from noon to 5 PM. Lunch and parking validation will be available.

Details: The event is from noon to 5 pm on Thursday, July 18, at the TMC Innovation Institute (2450 Holcombe Blvd. Suite, X, TMCx17 Board room). Learn more.

July 22 — TMC Biodesign Info Session

Do you want to start your own healthcare company? The TMC Biodesign Fellowship is a one-year paid innovation program that unites the talents of innovators and entrepreneurs with diverse backgrounds to quickly bring breakthrough healthcare products to market.

Details: The event is from 5 to 7 pm on Monday, July 22, at the TMC Innovation Institute (2450 Holcombe Blvd). Learn more.

July 25 — Managing Your Sales Function

Startups with a direct sales model have to evolve from founders doing all the sales to managing a sales function. Since revenue generation is on the line, the stakes are high and the punishment for mistakes are even higher. This supplement to the quarterly Founders Academy boot camp focuses on establishing and effectively managing the sales function for an early stage company.

    Details: The event is from 2 to 4 pm on Thursday, July 25, at The Cannon (1334 Brittmoore Road). Learn more.

    July 30 — Open Project Night with Impact Hub Houston and Sketch City

    Connect and collaborate with real, passionate people who are working on projects, ventures, and collaborations to improve to the city of Houston. If you have an idea, are working on something, or are looking for ways to collaborate with people who are doing work at the intersection of innovation and impact this event is for you.

    Details: The event is from 6 to 8 pm on Tuesday, July 30, at The Black Sheep Agency (611 West 22nd Street). Learn more.

    Ad Placement 300x100
    Ad Placement 300x600

    CultureMap Emails are Awesome

    Property Showcase

    Houston space company lands latest NASA deal to advance lunar logistics

    To The Moon

    Houston-based space exploration, infrastructure, and services company Intuitive Machines has secured about $2.5 million from NASA to study challenges related to carrying cargo on the company’s lunar lander and hauling cargo on the moon. The lander will be used for NASA’s Artemis missions to the moon and eventually to Mars.

    “Intuitive Machines has been methodically working on executing lunar delivery, data transmission, and infrastructure service missions, making us uniquely positioned to provide strategies and concepts that may shape lunar logistics and mobility solutions for the Artemis generation,” Intuitive Machines CEO Steve Altemus says in a news release.

    “We look forward to bringing our proven expertise together to deliver innovative solutions that establish capabilities on the [moon] and place deeper exploration within reach.”

    Intuitive Machines will soon launch its lunar lander on a SpaceX Falcon 9 rocket to deliver NASA technology and science projects, along with commercial payloads, to the moon’s Mons Mouton plateau. Lift-off will happen at NASA’s Kennedy Space Center in Florida within a launch window that starts in late February. It’ll be the lander’s second trip to the moon.

    In September, Intuitive Machines landed a deal with NASA that could be worth more than $4.8 billion.

    Under the contract, Intuitive Machines will supply communication and navigation services for missions in the “near space” region, which extends from the earth’s surface to beyond the moon.

    The five-year deal includes an option to add five years to the contract. The initial round of NASA funding runs through September 2029.

    Play it back: Houston home tech startup begins 2025 with fresh funding

    HOUSTON INNOVATORS PODCAST EPISODE 272

    One of the dozen or so Houston startups kicking of the new year with fresh funding is SmartAC.com, a company that's designed a platform that enables contractors in the HVAC and plumbing industries to monitor, manage, and optimize their maintenance memberships through advanced sensors, AI-driven diagnostics, and proactive alerts.

    Last month, the SmartAC.com raised a follow-on round with support from local investor Mercury to continue growth and expansion of the product, which has evolved on many ways since the company launched in 2020, emerging from stealth with $10 million raised in a series A. In a May 2023 interview for the Houston Innovators Podcast, Founder and CEO Josh Teekell explained how he embraced the power of a pivot.

    The company's sensors can monitor all aspects of air conditioning units and report back any issues, meaning homeowners have quicker and less costly repairs. While SmartAC.com started with providing the service and tech to homeowners directly, Teekell says he's had a greater interest in working with plumbers and HVAC companies who then deploy the technology to their customers.

    "It became quite evident that homeowners don't care about air conditioning really at all until their system breaks," Teekell says on the show. "The technology is really built around giving those contractors as another way to gain a customer relationship and keep it."

    Revisit the podcast episode below where Teekell talks about SmartAC.com's last raise.

    SmartAC.com's previous round in 2023 — a $22 million series B — was used grow its team that goes out to deploy the technology and train the contractors on the platform.

    "We've been very fortunate to get some of the biggest names in Houston on our cap table," Teekell says in the May 2023 conversation. "Since we're raising a bunch of money locally, everyone understands what a pain air conditioning can be."

    Houston biotech company tests hard-to-fight cancer therapeutics

    fighting cancer

    A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

    Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

    Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

    Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

    “There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

    The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

    Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

    Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

    The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

    The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.

    View All Listings